跳至主要内容
临床试验/NCT06136312
NCT06136312已完成不适用

A Clinical Investigation to Confirm Performance and Safety of the Multi4 System in Patients With Suspected Recurrent Bladder Cancer Lesions

Multi4 Medical Ab1 个研究点 分布在 1 个国家目标入组 18 人开始时间: 2023年12月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
18
试验地点
1
主要终点
Evaluable biopsies

研究概览

简要总结

A Clinical Investigation to Confirm Performance and Safety of the Multi4 System in Patients with Suspected Recurrent Bladder Cancer Lesions

详细描述

The overall purpose of this study is to confirm performance and safety of Multi4 Medical Device System when used as intended: to cauterize, remove, and automatically collect multiple tissue samples through the working channel of an endoscope.

The safety profile will be documented by collecting data on frequency and severity of complications, AEs such as bleeding and perforations.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Previous bladder cancer Ta/T1 G1-3
  • Recurrence of urinary superficial/ non-muscle-invasive bladder cancer visible at cystoscopy, estimated size < 10 mm
  • Willingness and ability to provide informed consent
  • Age ≥18 years

排除标准

  • Implantable Cardioverter Defibrillator (ICD) that cannot be inactivated
  • Current/ongoing untreated urinary tract infection
  • Pregnancy or breastfeeding
  • Be identified by the Investigator as inappropriate from a medical or compliance perspective to participate in this investigation

结局指标

主要结局

Evaluable biopsies

时间窗: At procedure

Biopsies collected by the instrument are evaluable by pathologist

次要结局

  • Time to perform procedure(At procedure)
  • Number of patients with complete procedures performed(At procedure)
  • Time for patient surveillance(At procedure)
  • Number of participants with treatment-related adverse events(One week)
  • Cost effectiveness(At procedure)
  • Patient-reported treatment-related pain (numeric rating scale)(At procedure)
  • Operator-reported ease of use(At procedure)
  • Quality of life (EQ-5D-5L)(At procedure and after 1 week)
  • Self reported satisfaction with procedure(One week)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验